Skip to main content
. 2024 Dec 4;15:1453176. doi: 10.3389/fimmu.2024.1453176

Table 3.

Treatment-related adverse events (TRAEs) based on CTCAE version 5.0.

Adverse events Grades 1–2, No. (%) Grades 3–4, No. (%)
Leukopenia 15 (31.9) 3 (6.4)
Thrombocytopenia 12 (25.5) 1 (2.1)
Anemia 14 (29.8) 0
Pruritu 11 (23.4) 0
Rash 22 (46.8) 0
Alopecia 39 (83.0) 0
Nausea and vomiting 31 (66.0) 0
Pneumonia 2 (4.3) 0
Joint and muscle pain 27 (57.4) 0
Liver injury 1 (2.1) 0
Cardiac involvement 0 1 (2.1)
Hyperglycaemia 0 1 (2.1)
Hypocorticism 1 (2.1) 1 (2.1)
Hypothyroidism 3 (6.4) 0